Sponsor Pipeline

Daiichi Sankyo Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
0
Recruiting
1
Phase 3
7
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04488822 A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT Tenosynovial Giant Cell Tumor Active, Not Recruiting
Phase 2
NCT04433234 Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy Active, Not Recruiting
NCT04458272 A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated… WHO Grade II Glioma Active, Not Recruiting
Phase 1
NCT03401385 First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01) Hormone Receptor Positive Breast Cancer Active, Not Recruiting
NCT02732275 DS-3201b in Participants With Lymphomas Lymphoma, Malignant Active, Not Recruiting
Disease Areas
Get alerts when Daiichi Sankyo Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free